In addition, CRIPTO knockdown inhibits proliferation of human MDA-MB-468 and SKBR3 breast cancer cell lines in vitro [18], while CRIPTO knockdown in a triple negative breast cancer (TNBC)-like transplantable mouse mammary tumor model blocks progression [19]. This evidence concerns the gene CRIPTO and breast carcinoma.